Awarepoint secures $27 million in Series F financing

NewsGuard 100/100 Score

Awarepoint Corporation, the leading provider of real-time location system (RTLS) solutions for healthcare, announced today that it has secured $27 million in Series F financing. New investor Kleiner Perkins Caufield & Byers (KPCB) led the round of financing, which also included participation from new investor Top Tier Capital Partners, and existing investors Cardinal Partners, Venrock, and Jafco Ventures. Awarepoint will use the capital to fuel the company's next stage of growth and drive further adoption of its pioneering aware360Platform.

Awarepoint's aware360Suite of RTLS-enabled solutions help hospital clients reduce hard operating costs, boost top-line revenues, and increase compliance management and patient satisfaction. Clients have deployed Awarepoint's patented technology and software platforms in the areas of asset management & tracking, rental reduction, temperature monitoring, hand hygiene, emergency, and perioperative departmental workflow and throughput, and enterprise patient tracking and workflow automation.

"Awarepoint delivers innovative technology and software solutions to healthcare providers enabling them to uniquely address escalating costs and compliance challenges, which is why KPCB is so excited to be an investor in the company," said KPCB partner Dana Mead.

"The current investors are thrilled to welcome KPCB to the investor group and board of directors of Awarepoint. We continue to be excited about the growth prospects of Awarepoint and are pleased with the strong execution of the company this past year," said Brandon Hull, general partner of Cardinal Partners and member of the Awarepoint Board of Directors.

"This past quarter saw Awarepoint book more business than all of last year combined and have the highest volume of new client activations in the company's history. We are incredibly pleased with the continued support of our board and current investor group and excited that KPCB has joined the Awarepoint team," said Jay Deady, president and chief executive officer of Awarepoint.  "This round of funding will allow us to continue the major market success achieved during the first half of the year, increase investment in research and development, as well as adding additional client support resources."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FUJIFILM Healthcare Europe introduces EndoGel training model for endoscopic procedures